Centiva Capital »

ADC Therapeutics SA shares owned by Centiva Capital

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 18k 1.07

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust St Str Sp Regbnk (KRE)
Vaneck Etf Trust Semiconductr Etf (SMH)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Marvell Technology (MRVL)

View all positions for Centiva Capital

Top funds holding ADC Therapeutics SA

Nantahala Capital Management
Redmile Group
TCG Crossover Management
Prosight Management
BlackRock
Morgan Stanley
Point72 Asset Management
Millennium Management
Citadel Advisors
Goldman Sachs Group
State Street Corporation
Geode Capital Management
Bank of America Corporation
Vanguard Portfolio Management
Two Sigma Investments

View all funds holding ADC Therapeutics SA